Are there health issues with low Anti-TG antibodies?

Low Anti-TG antibodies are generally a sign of good thyroid health, not a health concern. These antibodies attack thyroid tissue when elevated, so having low or undetectable levels means your immune system isn't targeting your thyroid gland.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Anti-TG Antibodies

Anti-thyroglobulin antibodies (Anti-TG or TgAb) are autoantibodies that your immune system produces against thyroglobulin, a protein made by your thyroid gland. Thyroglobulin plays a crucial role in producing thyroid hormones T3 and T4, which regulate your metabolism, energy levels, and numerous bodily functions.

When your immune system mistakenly identifies thyroglobulin as a foreign threat, it creates these antibodies to attack it. This autoimmune response can damage thyroid tissue and interfere with normal thyroid function. However, having low or undetectable Anti-TG antibodies is actually what you want to see in your blood work.

Why Low Anti-TG Antibodies Are Healthy

Unlike many blood markers where both high and low levels can indicate problems, Anti-TG antibodies are different. Low or undetectable levels (typically less than 4 IU/mL, though reference ranges vary by lab) indicate that your immune system is not attacking your thyroid gland. This is the ideal scenario and suggests good thyroid health from an autoimmune perspective.

Anti-TG Antibody Levels and Clinical Significance

Anti-TG LevelInterpretationHealth ImplicationsRecommended Action
<4 IU/mL<4 IU/mLNormal/NegativeNo autoimmune thyroid activityContinue healthy lifestyle, retest in 3-5 years
4-40 IU/mL4-40 IU/mLBorderlinePossible early autoimmune activityMonitor annually, test complete thyroid panel
>40 IU/mL>40 IU/mLElevated/PositiveActive autoimmune thyroid disease likelyConsult healthcare provider, complete thyroid workup
>500 IU/mL>500 IU/mLSignificantly ElevatedStrong autoimmune activity, high risk of thyroid dysfunctionImmediate medical evaluation needed

Reference ranges may vary by laboratory. Always interpret results in context with symptoms and other thyroid markers.

Think of Anti-TG antibodies like smoke detectors for thyroid autoimmunity. When they're quiet (low levels), it means there's no fire (autoimmune attack). You wouldn't worry about a smoke detector that isn't going off - similarly, low Anti-TG antibodies simply mean your thyroid isn't under autoimmune attack.

The Protective Nature of Low Antibody Levels

Having low Anti-TG antibodies offers several protective benefits:

  • Reduced risk of developing autoimmune thyroid conditions like Hashimoto's thyroiditis or Graves' disease
  • Better preservation of thyroid tissue and function over time
  • Lower likelihood of thyroid-related symptoms such as fatigue, weight changes, or temperature sensitivity
  • Decreased risk of thyroid nodules or goiter development related to autoimmune inflammation

When High Anti-TG Antibodies Become Problematic

To understand why low Anti-TG antibodies are beneficial, it helps to know what happens when they're elevated. High Anti-TG antibodies (typically above 40 IU/mL, though this varies) can indicate:

  • Hashimoto's thyroiditis - the most common cause of hypothyroidism in developed countries
  • Graves' disease - an autoimmune condition causing hyperthyroidism
  • Postpartum thyroiditis - temporary thyroid inflammation after pregnancy
  • Subacute thyroiditis - thyroid inflammation often following a viral infection

When Anti-TG antibodies are elevated, they can interfere with thyroid hormone production and lead to symptoms like chronic fatigue, unexplained weight gain or loss, hair loss, mood changes, and irregular menstrual cycles. This is why maintaining low antibody levels is associated with better overall health outcomes.

The Complete Thyroid Testing Picture

While low Anti-TG antibodies are reassuring, they're just one piece of the thyroid health puzzle. A comprehensive thyroid evaluation should include multiple markers to get a complete picture of your thyroid function.

Essential Thyroid Biomarkers

For a thorough thyroid assessment, consider testing these key biomarkers:

  • TSH (Thyroid Stimulating Hormone) - The primary screening test for thyroid function
  • Free T4 - The inactive thyroid hormone that converts to active T3
  • Free T3 - The active thyroid hormone that drives metabolism
  • Anti-TPO antibodies - Another autoimmune marker often elevated alongside Anti-TG

Testing all these markers together provides a comprehensive view of both thyroid function and autoimmune activity. Even with low Anti-TG antibodies, you could still have thyroid dysfunction from other causes, making complete testing essential for accurate diagnosis.

Who Should Monitor Anti-TG Antibodies

While having low Anti-TG antibodies is positive, certain groups should still monitor these levels regularly:

High-Risk Populations

  • People with a family history of thyroid disease or autoimmune conditions
  • Women planning pregnancy or who are postpartum
  • Individuals with other autoimmune diseases like Type 1 diabetes or celiac disease
  • Those experiencing unexplained thyroid symptoms despite normal TSH levels
  • People with a history of thyroid cancer (Anti-TG can be used as a tumor marker)

For these groups, maintaining low Anti-TG antibodies is particularly important, and regular monitoring can help catch any changes early before symptoms develop.

Maintaining Healthy Antibody Levels

If you have low Anti-TG antibodies, there are several strategies to help keep them that way and support overall thyroid health:

Nutritional Support

  • Ensure adequate selenium intake through foods like Brazil nuts, seafood, and eggs
  • Maintain sufficient vitamin D levels through sun exposure and supplementation if needed
  • Include iodine-rich foods in moderation (too much or too little can affect thyroid function)
  • Consume anti-inflammatory foods rich in omega-3 fatty acids

Lifestyle Factors

  • Manage stress through meditation, yoga, or other relaxation techniques
  • Prioritize quality sleep, aiming for 7-9 hours nightly
  • Exercise regularly but avoid overtraining, which can stress the thyroid
  • Limit exposure to environmental toxins and endocrine disruptors

When to Test Your Thyroid Antibodies

Even if you have low Anti-TG antibodies, certain situations warrant retesting:

  • Development of new thyroid symptoms like fatigue, weight changes, or temperature sensitivity
  • During pregnancy planning or postpartum periods
  • After diagnosis of another autoimmune condition
  • If you have a strong family history of thyroid disease
  • As part of regular health monitoring if you're in a high-risk group

For most people without risk factors or symptoms, testing thyroid antibodies every few years as part of comprehensive health screening is sufficient. However, those with risk factors may benefit from annual monitoring.

The Bottom Line on Low Anti-TG Antibodies

Having low Anti-TG antibodies is a positive health indicator, not a cause for concern. It means your immune system is not attacking your thyroid gland, reducing your risk of autoimmune thyroid conditions and their associated symptoms. Unlike many blood markers where balance is key, with Anti-TG antibodies, lower is definitively better.

However, remember that thyroid health involves more than just antibody levels. Complete thyroid testing, including TSH, Free T3, Free T4, and Anti-TPO antibodies, provides the most comprehensive picture of your thyroid function. Regular monitoring, especially if you have risk factors, can help you maintain optimal thyroid health throughout your life.

References

  1. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489-499.[PubMed][DOI]
  2. McLeod DS, Cooper DS. The incidence and prevalence of thyroid autoimmunity. Endocrine. 2012;42(2):252-265.[PubMed][DOI]
  3. Sinclair D. Clinical and laboratory aspects of thyroid autoantibodies. Ann Clin Biochem. 2006;43(Pt 3):173-183.[PubMed][DOI]
  4. Spencer CA. Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC). J Clin Endocrinol Metab. 2011;96(12):3615-3627.[PubMed][DOI]
  5. Vanderpump MP. The epidemiology of thyroid disease. Br Med Bull. 2011;99:39-51.[PubMed][DOI]
  6. Fröhlich E, Wahl R. Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases. Front Immunol. 2017;8:521.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my Anti-TG antibodies at home?

You can test your Anti-TG antibodies at home with SiPhox Health's Core Health Program by adding the Thyroid+ expansion, which includes TPOAb, Free T4, and Free T3 testing along with the base TSH test for comprehensive thyroid assessment.

What is the normal range for Anti-TG antibodies?

Normal Anti-TG antibody levels are typically less than 4 IU/mL, though reference ranges can vary between laboratories. Some labs use less than 20 IU/mL as their normal range. Low or undetectable levels within these ranges indicate healthy thyroid function without autoimmune activity.

Can Anti-TG antibodies be too low?

No, Anti-TG antibodies cannot be too low. Unlike many blood markers, there is no lower limit of concern for these antibodies. Undetectable or zero levels are ideal and indicate your immune system is not attacking your thyroid tissue.

Should I worry if my Anti-TG antibodies are undetectable?

Undetectable Anti-TG antibodies are actually the best possible result. This means your immune system is not producing antibodies against your thyroid, indicating no autoimmune thyroid activity and a lower risk of developing conditions like Hashimoto's thyroiditis.

How often should I retest Anti-TG antibodies if they're low?

If you have low Anti-TG antibodies and no symptoms or risk factors, retesting every 3-5 years is typically sufficient. However, those with family history of thyroid disease, other autoimmune conditions, or thyroid symptoms should consider annual testing.

Can low Anti-TG antibodies increase over time?

Yes, Anti-TG antibodies can increase over time, especially in response to triggers like stress, illness, pregnancy, or environmental factors. This is why periodic monitoring is recommended for those with risk factors, even if current levels are low.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details